Title: Comparative Study of Endometrial Aspiration Cytology Using Pipelle with Hysteroscopic Guided Endometrial Biopsy in Patient with AUB (Abnormal Uterine Bleeding)

Authors: Dr Shivangi, Prof Dr Tapasi Pati, Prof Dr Debahuti Mohapatra

 DOI: https://dx.doi.org/10.18535/jmscr/v9i1.50

Abstract

Abnormal uterine bleeding is one of the most common problems in perimenopausal age group. The proportion is 9-30% in reproductive age group. This proportion rises to 70% in perimenopausal and postmenopausal women. Abnormal uterine bleeding (AUB) warrants a thorough evaluation in perimenopausal women and hence it’s important to perform it in a cost-effective manner with available resources.

Aims and Objectives: Compare the efficacy of endometrial cytology with hysteroscopy guided biopsy.

Inclusion Criteria: women above 35 years of age with symptoms suggestive of AUB.

Exclusion Criteria: Pregnant patient and patient with genital tract infection, coagulation disorder and genital malignancy.

Conclusion: Endometrial sampling using Pipelle is an easy and safe method. It has high sensitivity, specificity, positive and negative predictive values when compared to hysteroscopy. Thus, to obtain adequate endometrial sample, Pipelle biopsy should be considered as primary investigation.

Keywords: Abnormal uterine bleeding, FIGO, PALM-COEIN.

References

  1. Munro MG, Critchley HO, Broder MS, Fraser IS; FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J GynaecolObstet2011;113:3-13.
  2. Tavassoli FA, Devilee pathology and genetics of tumours of breast and female genital organs. WHO classifications of tumors. Lyon,France:IARC press 2003:221-232.
  3. Yasmin F, Farrukh R, Kamal F. Efficacy of pipelle as a tool for endometrial biopsy. Biomedica 2007; 23:116-9.
  4. Rosai J. Female reproductive system-uterus-corpus. In: RosaiJ,ed.Rosai and Ackerman’s surgical pathology.9th vol.2. New delhi: Elsevier 2004:P 1569-1635.
  5. Shams G. Comparison of pipelle de cornier with conventional dilatation and curettage in terms of patients' acceptability. J Postgrad Med Inst (Peshawar-Pakistan) 2012;26:418-21.
  6. Rodriguez GC, Yaqub N, King ME. A comparison of the pipelle device and vibra aspirator as measured by endometrial denudation in hysterectomy specimens. Am J Obstet Gynecol 1993;168(1 pt 1):55-59.
  7. Guido RS, Kanbour-shakir A, Rulin MC et al. Pipelle endometrial sampling sensitivity in the detection of endometrial cancer. J Repord Med 1995;40(8):553-555.
  8. The American Cancer Society Medical and Editorial Content Team. (2016). Survival rates for ovarian cancer, by stage.
  9. org/cancer/ovarian-cancer/detection-diagnosis-staging/survival-rates.html
  10. Goh W, Bohrer J, Zalud I. Management of the adnexal mass in pregnancy. Curr Opin Obstet Gynecol. 2014;26(2):49-53.
  11. Stoval TG, Ling FW,  Morgan    A prospective, randomized comparison  of  the  pipelle  endometrial sampling device with the novak curette. Am J Obstet Gynecol.1991;165:1287-90.
  12. Altman D, Granath F, Cnattingius S, Falconer C. Hysterectomy and risk for stress-urinary-incontinence surgery: nationwide cohort study. Lancet, 2007; 370, 1494–1499.
  13. Ben-Baruch G, Seidman DS, Schiff E, Moran O, Menczer J. Outpatient endometrial sampling with the Pipelle curette. Gynecol Obstet Invest. 1994;37(4):260-2.
  14. Guido RS, Kanbour-shakir A, Rulin MC. et al. Pipelle endometrial sampling sensitivity in the detection of endometrial cancer. J Reprod Med 1995;40(8):553-555.
  15. Van den Bosch T, Vandendael A, Wranz PA, Lombard CJ. Endopap-versus Pipelle-sampling in the diagnosis of postmenopausal endometrial disease. Eur J Obstet Gynecol Reprod Biol. 1996;64 (1):91-4.
  16. Bunyavejchevin S, Triratanachat S, Kankeow K, Limpaphayom KK. Pipelle versus fractional curettage for the endometrial sampling in postmenopausal women. J Med Assoc Thai. 2001;84 Suppl 1:S326-30.
  17. Bain C, Parkin DE, Cooper KG. Is outpatient diagnostic hysteroscopy more useful than endometrial biopsy alone for the investigation of abnormal uterine bleeding in unselected premenopausal women? A randomised comparison. BJOG. 2002;109(7):805-11.
  18. Dangal G. A study of endometrium of patients with abnormal uterine bleeding at Chitwan Valley. Kathmandu Univ Med J (KUMJ). 2003;1(2):110-2.
  19. Tanriverdi HA, Barut A, Gün BD, Kaya E. Is pipelle biopsy really adequate for diagnosing endometrial disease? Med Sci Monit. 2004 Jun;10(6):CR271-4.
  20. Garuti G, Sambruni I, Colonnelli M, Luerti M. Accuracy of hysteroscopy in predicting histopathology of endometrium in 1500 women. J Am Assoc Gynecol Laparosc. 2001;8(2):207-13.
  21. Fujiwara H, Takahashi Y, Takano M, Miyamoto M, Nakamura K, Kaneta Y, et al. Evaluation of endometrial cytology: cytohistological correlations in 1,441 cancer patients. Oncology. (2015) 88:86–94.
  22. Fulciniti F, Yanoh K, Karakitsos P, Watanabe J, Di LA, Margari N, et al. The Yokohama system for reporting directly sampled endometrial cytology: the quest to develop a standardized terminology. Diagnost Cytopathol. (2018) 46:400–12.
  23. Tingthanatikul Y, Choktanasiri W, Rochanawutanon M, Weerakeit S. Prevalence and clinical predictors of endometrial hyperplasiain anovulatory women presenting with amenorrhea. Gynecol Endocrinol 2006;22:101-5.
  24. Timmermans A, Opmeer BC, Khan KS, Bachmann LM, Epstein E, Clark TJ, et al. Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: A systematic review and meta-analysis. Obstet Gynecol2010;116:160-7.

Corresponding Author

Prof Dr Debahuti Mohapatra